Clincosm LogoSign in Get a demo

Calculating of Correlations Between ADR, PDR, MAP

Sponsor
Hospital Frydek-Mistek (Other)
Overall Status
Completed
CT.gov ID
NCT03723720
Collaborator
(none)
6,925
Enrollment
59
Actual Duration (Months)

Study Details

Study Description

Brief Summary

The aim of our study is to compare MAP (mean adenoma per colonoscopy) with ADR (adenoma detection rate) and PDR (polyp detection rate) of all colonoscopists in our department

Condition or Disease Intervention/Treatment Phase
  • Device: Colonoscopy

Detailed Description

ADR (adenoma detection rate) is generally accepted quality indicator. For possible gaming with ADR other indicators are needed. MAP (mean adenoma per colonoscopy) reflects the quality of examination of entire colon and is considered to be the most objective quality indicator. The aim of our study is to compare MAP with ADR and PDR (polyp detection rate) of all colonoscopists in our department.

We want to retrospectively assess the quality indicators of all colonoscopies from January 2013 to December 2017. We want to calculate ADR, PDR and MAP of all our endoscopists for all colonoscopies in patients over 50 years of age excluding therapeutic, IBD, management of complications and sigmoidoscopies (screening, surveillance, diagnostic) and separately only for screening colonoscopies. Correlations between MAP/ADR and MAP/PDR will be performed using Pearson´s correlation coefficient.

Study Design

Study Type:
Observational
Actual Enrollment :
6925 participants
Observational Model:
Other
Time Perspective:
Retrospective
Official Title:
Calculating of Correlations Between ADR, PDR, MAP
Actual Study Start Date :
Jan 1, 2013
Actual Primary Completion Date :
Dec 1, 2017
Actual Study Completion Date :
Dec 1, 2017

Arms and Interventions

Arm Intervention/Treatment
Patients after colonoscopy over 50 years

All colonoscopies in patients over 50 years of age (screening, surveillance, diagnostic) excluding therapeutic, IBD, management of complications and sigmoidoscopies

Device: Colonoscopy
Endoscopic examination of large bowel

Outcome Measures

Primary Outcome Measures

  1. correlation between MAP and ADR for all and screening colonoscopies [january 2013 - december 2017]

    Pearson´s correlation coefficient

  2. correlation between MAP and PDR for all and screening colonoscopies [january 2013 - december 2017]

    Pearson´s correlation coefficient

  3. correlation between ADR and PDR for all and screening colonoscopies [january 2013 - december 2017]

    Pearson´s correlation coefficient

Eligibility Criteria

Criteria

Ages Eligible for Study:
50 Years and Older
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
No
Inclusion Criteria:
  • people over 50 years of age coming for colonoscopic examination (screening, surveillance, diagnostic)
Exclusion Criteria:

  • age under 50 years

  • indication for colonoscopy: therapeutic, IBD, management of complications and sigmoidoscopies

Contacts and Locations

Locations

No locations specified.

Sponsors and Collaborators

  • Hospital Frydek-Mistek

Investigators

  • Principal Investigator: Ivana Mikoviny Kajzrlikova, Doctor

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
Ivana Mikoviny Kajzrlikova, MD, PhD, MD, Hospital Frydek-Mistek
ClinicalTrials.gov Identifier:
NCT03723720
Other Study ID Numbers:
  • MAP
First Posted:
Oct 29, 2018
Last Update Posted:
Oct 29, 2018
Last Verified:
Oct 1, 2018
Individual Participant Data (IPD) Sharing Statement:
Undecided
Plan to Share IPD:
Undecided
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Additional relevant MeSH terms:
Colonic Neoplasms

Study Results

No Results Posted as of Oct 29, 2018